Transition Therapeutics Inc.

Home | Contact us | Disclaimer

Corporate Overview Management Board of Directors Contact us Business Ethics
Product pipeline Alzheimer's disease Bipolar disorder Diabetes and obesity Inflammatory diseases
Current partnership In/Out-licensing opportunity
Agitation/aggression in AD Bipolar disorder Diabetes and obesity Cognition/function in AD
Stock quote Financial reports Analyst coverage Request information Subscribe to e-mail alert
Press release 2013 Press release archive Webcast and presentation

INVESTOR relations

Stock Quotes

Financial Reports

Analyst Coverage

Insider Trading (SEDI)

Request Information

E-mail Alert

You may automatically receive Transition Therapeutics' press releases by e-mail. Please fill out the form below to subscribe or unsubscribe the e-mail alert: